Relative Bioavailability Study of MELT-100, IV Midazolam, and IV Ketamine
Status:
Completed
Trial end date:
2021-01-14
Target enrollment:
Participant gender:
Summary
A Pivotal Phase 1, Randomized, Single-Dose, 4-Period, Crossover Relative Bioavailability
Study of MELT-100, IV Midazolam, and IV Ketamine under Fasted Conditions in Healthy
Volunteers